In two independent experiments, mice targeted with sgGata4 exhibited increased tumor burden at 16 weeks when compared to sgCtrl mice, suggesting a Gata4-dependent tumor suppressive phenotype (Fig. 1c). Here, GATA4 is linked to neoplasm.